Bharat Biotech submits Covaxin phase 3 trials data to DCGI

Bharat Biotech has submitted data from phase 3 trials of the Covaxin vaccine to the Drugs Controller General of India (DCGI). Covaxin is among three vaccines being used in the nationwide drive against Covid-19. It was granted approval by the DCGI in January, along with the Oxford University-AstraZeneca Vaccine which is being manufactured by the … Continue reading Bharat Biotech submits Covaxin phase 3 trials data to DCGI